dihexa hgf c-met potentiator HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence HGF/c-MET: A Promising Therapeutic Target
HGF c MET: A Promising Therapeutic Target in the Digestive System Cancers Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted Noncoding Microdeletion in Mouse Hgf Disrupts Neural Crest Migration into the Stria Vascularis, Reduces the Endocochlear Potential, and Suggests the Neuropathology for Human Nonsyndromic Deafness DFNB39 Journal of Neuroscience HGF independent potentiation of EGFR action by c Met Oncogene
Pay in 4 interest-free payments of $5.55 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9


